FDA Dings Drugmakers Over Missing Pediatric Studies
The U.S. Food and Administration is widening its criticism of pharmaceutical companies that haven't completed mandatory post-approval studies of their products' safety and effectiveness in children, although Pfizer Inc. and others...To view the full article, register now.
Already a subscriber? Click here to view full article